We are live on ! Find out more
LFCR icon

Lifecore Biomedical
LFCR

92 hedge funds and large institutions have $235M invested in Lifecore Biomedical in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 26 increasing their positions, 34 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.16% more ownership

Funds ownership: 86.53% → 86.68% (+0.16%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

3% less funds holding

Funds holding: 95 → 92 (-3)

13% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 16

17% less capital invested

Capital invested by funds: $285M → $235M (-$49.9M)

24% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 34

89% less call options, than puts

Call options by funds: $11K | Put options by funds: $98K

Holders
92
Holders Change
-3
Holders Change %
-3.16%
% of All Funds
1.61%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
26
Reduced
34
Closed
16
Calls
$11K
Puts
$98K
Net Calls
-$87K
Net Calls Change
+$158K

Top Buyers

Rank Fund Capital Flow
1
ICM
ISZO Capital Management
New York
+$17.9M
2
Morgan Stanley
Morgan Stanley
New York
+$6.05M
3
William Blair Investment Management
William Blair Investment Management
Illinois
+$4.61M
4
2L
22NW LP
Washington
+$3.3M
5
ERSOT
Employees Retirement System of Texas
Texas
+$929K

Top Sellers

Rank Fund Capital Flow
1
WC
Walthausen & Co
New York
-$4.36M
2
JGC
J. Goldman & Co
New York
-$2.42M
3
Russell Investments Group
Russell Investments Group
United Kingdom
-$2.33M
4
SCM
SG Capital Management
Illinois
-$1.63M
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$1.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$1.03M -$1.39M -127,846 -53%
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$969K +$152K +13,954 +15%
Millennium Management
28
Millennium Management
New York
$912K +$283K +26,039 +36%
Wells Fargo
29
Wells Fargo
California
$825K +$666K +61,182 +216%
ERSOT
30
Employees Retirement System of Texas
Texas
$787K +$929K +85,400 New
Boston Partners
31
Boston Partners
Massachusetts
$759K -$495K -45,463 -36%
CIP
32
Chartwell Investment Partners
Pennsylvania
$749K -$17K -1,560 -2%
AA
33
Ancora Advisors
Ohio
$729K – – –
RA
34
Royce & Associates
New York
$697K – – –
Charles Schwab
35
Charles Schwab
California
$612K -$1.21M -111,531 -63%
Swiss National Bank
36
Swiss National Bank
Switzerland
$596K – – –
Invesco
37
Invesco
Georgia
$590K +$35.3K +3,247 +5%
PCM
38
Perritt Capital Management
Illinois
$582K – – –
DC
39
Defender Capital
North Carolina
$553K +$218K +20,000 +50%
AQR Capital Management
40
AQR Capital Management
Connecticut
$550K +$33.4K +3,073 +5%
GI
41
GAMCO Investors
Connecticut
$545K +$137K +12,582 +27%
JP Morgan Chase
42
JP Morgan Chase
New York
$536K -$458K -42,061 -42%
D.E. Shaw & Co
43
D.E. Shaw & Co
New York
$496K -$517K -47,508 -47%
OAM
44
Oppenheimer Asset Management
New York
$496K +$37.2K +3,423 +7%
JGC
45
J. Goldman & Co
New York
$427K -$2.42M -222,120 -83%
Squarepoint
46
Squarepoint
New York
$412K +$38.4K +3,525 +9%
GCP
47
GSA Capital Partners
United Kingdom
$370K +$437K +40,153 New
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$365K +$8.23K +756 +2%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$352K +$23.3K +2,137 +6%
Goldman Sachs
50
Goldman Sachs
New York
$338K -$610K -56,102 -61%
1
2
3 4 5

LFCR Hedge Fund Activity: Q3 2021 in Review

92 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Lifecore Biomedical (LFCR) for Q3 2021, worth a combined $235M — down 17% from $285M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of LFCR and 14 opened new positions — a net loss of 2 holders — while 34 trimmed existing stakes and 26 added.

The largest buyer was ISZO Capital Management, opening a new position worth an estimated $17.9M. The largest seller was Walthausen & Co, exiting entirely with an estimated $4.36M sold.

  • 92 institutional investors held Lifecore Biomedical (LFCR) as of Q3 2021, down from 95 in Q2 2021.
  • Funds reported $235M of Lifecore Biomedical stock for Q3 2021, down 17% quarter-over-quarter.
  • 14 funds opened new Lifecore Biomedical positions in Q3 2021 and 16 closed out, a net change of -2 holders.
  • The largest Lifecore Biomedical buyer in Q3 2021 was ISZO Capital Management, an estimated $17.9M added.
  • The largest Lifecore Biomedical seller in Q3 2021 was Walthausen & Co, an estimated $4.36M sold.

Based on aggregated 13F filings for Q3 2021.